Matthew W. Foehr, Former Executive Officer at Ligand Pharma, holds 2.91M shares in OmniAb (Ticker: OABI), holds 162.19K shares in Ligand Pharma (Ticker: LGND), holds 0.00 shares in OmniAb, Inc. (Ticker: OABIV). Most recently, Matthew W. Foehr Bought ― shares of OmniAb on Mar 25, 2024 for an estimated value of 1.17M.